IDEXX Laboratories Stock Price and Value Analysis

Should you buy IDEXX Laboratories stock? (NasdaqGS:IDXX). Let's see how it does in our automated value investing analysis system.

  • This company has fluctuating growth.
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the IDXX Numbers

IDXX Price
(IDEXX Laboratories stock price per share)
[?] IDXX Fair Price
(based on intrinsic value)
[?] IDXX Safety Price (based on a variable margin of safety) $10.27
[?] PE Ratio versus Sector 205% higher than other Healthcare stocks
[?] PE Ratio versus Industry 62% lower than other Diagnostics & Research stocks
[?] Cash Yield 0.58%
[?] Free Cash Flow Jitter 26%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,371,365 shares shorted. With 82,392,862 shares available for purchase and an average trading volume over the past 10 trading days of 404,730, it would take at least 5.859 days for all of the short holders to cover their shorts.

Is IDEXX Laboratories Stock on Sale?

We believe that IDEXX Laboratories may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

IDEXX Laboratories looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy IDXX Stock?

Does IDEXX Laboratories have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.